Business Context and Reporting Period
This Form 8-K is a current report filed by Leisure Acquisition Corp. (not Ensysce Biosciences, Inc., as indicated in the metadata) on December 5, 2017, regarding events occurring on December 1, 2017. The registrant is a Delaware corporation and an emerging growth company. The filing details the consummation of its Initial Public Offering (IPO) and related private placement transactions.
Key Financial Metrics
- IPO Gross Proceeds: $200,000,000 from the sale of 20,000,000 Units at $10.00 per Unit.
- Private Placement Proceeds: Approximately $6,825,000 from the sale of 6,825,000 Private Placement Warrants at $1.00 per warrant.
- Total Capital Raised: Approximately $206,825,000.
- Trust Account Funding: $200,000,000 placed in trust (comprising $196,000,000 from IPO proceeds, including $7,000,000 deferred underwriting discount, and $4,000,000 from private placement proceeds).
- Warrant Exercise Price: $11.50 per share.
- Revenue, Profit, and Cash Flow: The filing text does not provide operating revenue, profit, or cash flow metrics as the company is a special purpose acquisition company (SPAC) in its pre-business combination phase.
Material Changes
The primary material change is the transition from a private entity to a publicly traded company following the IPO. Key structural changes include:
- Issuance of 20,000,000 Units, each consisting of one share of Common Stock and one-half of one Warrant.
- Establishment of a trust account holding $200,000,000 to fund a future business combination or shareholder redemptions.
- Execution of multiple agreements including a Warrant Agreement, Investment Management Trust Agreement, Registration Rights Agreement, and a Contingent Forward Purchase Contract with HG Vora Special Opportunities Master Fund, Ltd.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The Company must complete its initial business combination within 24 months from the closing of the IPO (December 5, 2017).
- Redemption Rights: Public shareholders may redeem their shares if the Company fails to complete a business combination within the 24-month period or if shareholders vote to amend the certificate of incorporation regarding redemption obligations.
- Trust Account Restrictions: Funds in the trust account generally cannot be released until the completion of a business combination, a redemption event, or to pay franchise and income taxes on interest earned.
- Private Placement Warrants: These warrants are non-transferable for 30 days after the initial business combination and are not redeemable by the Company while held by the purchasers.
Investor Verification Checklist
- Verify the exact date of the IPO closing (December 5, 2017) versus the report date (December 1, 2017) to confirm the 24-month business combination deadline.
- Confirm the terms of the Contingent Forward Purchase Contract with HG Vora to understand potential future capital commitments.
- Review the deferred underwriting discount of $7,000,000 to assess future cash outflows upon a successful business combination.
- Check the specific redemption thresholds and procedures outlined in the Second Amended and Restated Certificate of Incorporation.
- Validate the identity of the Sponsors (Matthews Lane Capital Partners and Hydra Management) and their ongoing financial support obligations.